A protein once thought to simply help cancer cells avoid death turns out to do much more. MCL1 actively drives cancer ...

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

Scientists have uncovered evidence that two defining features of cancer are driven by the same underlying molecular process. These features include ...

Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call.

Since the launch of the Crossword in 1942, The Times has captivated solvers by providing engaging word and logic games. In 2014, we introduced the Mini Crossword — followed by Spelling Bee, Letter ...

Continuing Phase 3 Enabling Activities, Including Discussions with U.S. Food & Drug Administration (FDA) Following Positive Phase 2b RSVHR Results for Zelicapavir, an N-Protein Inhibitor in ...